Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Dusseldorf - Delayed Quote • EUR Mirum Pharmaceuticals Inc (08D.DU) Follow Add holdings 35.00 +0.40 +(1.16%) As of 4:30:27 PM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 08D.DU 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 08D.DU View More All News Press Releases SEC Filings Mirum’s LIVMARLI Now FDA Approved in Tablet Formulation Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Avidity Biosciences (RNA) Soars 11.3%: Is Further Upside Left in the Stock? Mirum Pharmaceuticals (MIRM) Down 1.9% Since Last Earnings Report: Can It Rebound? LIVMARLI Now Approved in Japan for ALGS and PFIC Exploring 3 High Growth Tech Stocks in the US Market Analyst Estimates: Here's What Brokers Think Of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) After Its Full-Year Report Mirum Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations Q4 2024 Mirum Pharmaceuticals Inc Earnings Call MIRM's Q4 Loss Wider Than Expected, Revenues Beat Estimates Mirum Pharmaceuticals Inc (MIRM) Q4 2024 Earnings Call Highlights: Record Sales Surge and ...